Tanya L Harlow, | |
700 1st Ave S, Fargo, ND 58103-1802 | |
(701) 234-4036 | |
(701) 234-4160 |
Full Name | Tanya L Harlow |
---|---|
Gender | Female |
Speciality | Neurology |
Experience | 21 Years |
Location | 700 1st Ave S, Fargo, North Dakota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740498104 | NPI | - | NPPES |
1740498104 | Other | HEALTHPARTNERS | |
1740498104 | Other | ND | MEDICA |
14742 | Medicaid | ND | |
54281 | Other | IA | WELLMARK BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | 37088 (Iowa) | Secondary |
2084N0400X | Psychiatry & Neurology - Neurology | 10864 (North Dakota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Sanford Medical Center Fargo | Fargo, ND | Hospital |
Sanford Medical Center Bismarck | Bismarck, ND | Hospital |
Perham Health | Perham, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Bhsm Rehabilitation Llc | 2062773138 | 1258 |
Sanford Medical Center Fargo | 8426967803 | 1094 |
Sanford Bismarck | 9739098575 | 448 |
News Archive
A study of first-episode psychosis patients in Hong Kong has found that those with fewer negative symptoms at presentation and poor medication compliance were more likely than others to disengage from an early intervention program.
Extended treatment with the antiretroviral drug nevirapine in conjunction with the standard therapy might reduce the risk of mother-to-child HIV transmission, according to a study published Wednesday in the New England Journal of Medicine, Reuters reports (Emery, Reuters, 6/4).
AbbVie (NYSE: ABBV) submitted a New Drug Application (NDA) to the Japanese Ministry of Health, Labour and Welfare (MHLW) seeking approval for the company's investigational, all-oral, ribavirin (RBV) and interferon (IFN)-free, 12-week, two direct-acting antiviral treatment of ombitasvir/paritaprevir/ritonavir (OBV/PTV/r), dosed once daily.
A third (34 per cent) of eczema management mobile applications provide information that does not agree with international treatment and condition guidelines, a study led by Nanyang Technological University, Singapore has found.
› Verified 4 days ago
Entity Name | Sanford Bismarck |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1811941172 PECOS PAC ID: 9739098575 Enrollment ID: O20031105000403 |
News Archive
A study of first-episode psychosis patients in Hong Kong has found that those with fewer negative symptoms at presentation and poor medication compliance were more likely than others to disengage from an early intervention program.
Extended treatment with the antiretroviral drug nevirapine in conjunction with the standard therapy might reduce the risk of mother-to-child HIV transmission, according to a study published Wednesday in the New England Journal of Medicine, Reuters reports (Emery, Reuters, 6/4).
AbbVie (NYSE: ABBV) submitted a New Drug Application (NDA) to the Japanese Ministry of Health, Labour and Welfare (MHLW) seeking approval for the company's investigational, all-oral, ribavirin (RBV) and interferon (IFN)-free, 12-week, two direct-acting antiviral treatment of ombitasvir/paritaprevir/ritonavir (OBV/PTV/r), dosed once daily.
A third (34 per cent) of eczema management mobile applications provide information that does not agree with international treatment and condition guidelines, a study led by Nanyang Technological University, Singapore has found.
› Verified 4 days ago
Entity Name | Sanford Clinic North |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942241351 PECOS PAC ID: 4284546151 Enrollment ID: O20031112000221 |
News Archive
A study of first-episode psychosis patients in Hong Kong has found that those with fewer negative symptoms at presentation and poor medication compliance were more likely than others to disengage from an early intervention program.
Extended treatment with the antiretroviral drug nevirapine in conjunction with the standard therapy might reduce the risk of mother-to-child HIV transmission, according to a study published Wednesday in the New England Journal of Medicine, Reuters reports (Emery, Reuters, 6/4).
AbbVie (NYSE: ABBV) submitted a New Drug Application (NDA) to the Japanese Ministry of Health, Labour and Welfare (MHLW) seeking approval for the company's investigational, all-oral, ribavirin (RBV) and interferon (IFN)-free, 12-week, two direct-acting antiviral treatment of ombitasvir/paritaprevir/ritonavir (OBV/PTV/r), dosed once daily.
A third (34 per cent) of eczema management mobile applications provide information that does not agree with international treatment and condition guidelines, a study led by Nanyang Technological University, Singapore has found.
› Verified 4 days ago
Entity Name | Sanford Medical Center Fargo |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184917924 PECOS PAC ID: 8426967803 Enrollment ID: O20110331000495 |
News Archive
A study of first-episode psychosis patients in Hong Kong has found that those with fewer negative symptoms at presentation and poor medication compliance were more likely than others to disengage from an early intervention program.
Extended treatment with the antiretroviral drug nevirapine in conjunction with the standard therapy might reduce the risk of mother-to-child HIV transmission, according to a study published Wednesday in the New England Journal of Medicine, Reuters reports (Emery, Reuters, 6/4).
AbbVie (NYSE: ABBV) submitted a New Drug Application (NDA) to the Japanese Ministry of Health, Labour and Welfare (MHLW) seeking approval for the company's investigational, all-oral, ribavirin (RBV) and interferon (IFN)-free, 12-week, two direct-acting antiviral treatment of ombitasvir/paritaprevir/ritonavir (OBV/PTV/r), dosed once daily.
A third (34 per cent) of eczema management mobile applications provide information that does not agree with international treatment and condition guidelines, a study led by Nanyang Technological University, Singapore has found.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Tanya L Harlow, 700 1st Ave S, Fargo, ND 58103-1802 Ph: (701) 234-4036 | Tanya L Harlow, 700 1st Ave S, Fargo, ND 58103-1802 Ph: (701) 234-4036 |
News Archive
A study of first-episode psychosis patients in Hong Kong has found that those with fewer negative symptoms at presentation and poor medication compliance were more likely than others to disengage from an early intervention program.
Extended treatment with the antiretroviral drug nevirapine in conjunction with the standard therapy might reduce the risk of mother-to-child HIV transmission, according to a study published Wednesday in the New England Journal of Medicine, Reuters reports (Emery, Reuters, 6/4).
AbbVie (NYSE: ABBV) submitted a New Drug Application (NDA) to the Japanese Ministry of Health, Labour and Welfare (MHLW) seeking approval for the company's investigational, all-oral, ribavirin (RBV) and interferon (IFN)-free, 12-week, two direct-acting antiviral treatment of ombitasvir/paritaprevir/ritonavir (OBV/PTV/r), dosed once daily.
A third (34 per cent) of eczema management mobile applications provide information that does not agree with international treatment and condition guidelines, a study led by Nanyang Technological University, Singapore has found.
› Verified 4 days ago
Susan L Scarberry, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 700 1st Ave S, Fargo, ND 58103 Phone: 701-234-4036 Fax: 701-234-4160 | |
Charlotte Marie Andersen, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 510 4th Street S, Fargo, ND 58107 Phone: 701-476-7200 | |
Dr. Lawana Marie Burtnett, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 510 4th St S, Fargo, ND 58103 Phone: 701-476-7200 | |
Dr. Ravinda Samaraweera, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 700 1st Ave S, Fargo, ND 58103 Phone: 701-234-4036 Fax: 701-234-4160 | |
Dr. Timothy T Vo, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2624 9th Ave S, Southeast Human Service Center, Fargo, ND 58103 Phone: 701-298-4500 Fax: 701-298-4400 | |
Karis Antonia Stenback Irving, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2101 Elm St Ne, Fargo, ND 58102 Phone: 615-918-0639 Fax: 612-749-3990 | |
Amna Masood, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 736 Broadway N, Fargo, ND 58102 Phone: 701-234-2000 Fax: 701-234-2345 |